CELL-MEDIATED IMMUNITY AND BLOCKING SERUM ACTIVITY TO TOLERATED ALLOGRAFTS IN RATS by Bansal, S. C. et al.
CELL-MEDIATED  IMMUNITY  AND  BLOCKING  SERUM  ACTIVITY 
TO  TOLERATED  ALLOGRAFTS  IN  RATS* 
BY S. C. BANSAL,~c  K. E.  HELLSTROM, I. HELLSTROM,  A~D H.  O.  SJOGREN 
(From the Department of Immunology, Fred Hutchinson Cancer Center; Departments of 
Pathology and Microbiology, University of Washington Medical School, Seattle, 
Washington 99195; and the Department of Medical Microbiology, The U~iversity 
of Lund, Lund, Sweden) 
(Received for publication 11 October 1972) 
Animals neonatally inoculated with  allogeneic tissues often become tolerant, i.e., 
capable of  later in  life accepting allografts containing  the  respective antigens  (1). 
A  widely  accepted  explanation  for  tolerance  induced  by  neonatal  inoculation  of 
allogeneic cells postulates that those lymphoid cell clones that would have been capa- 
ble of reacting against the tolerated antigens have been either killed or irreversibly 
suppressed from reacting (2, 3). It has also been hypothesized, however, that at least 
part of the tolerance phenomenon, as induced against allografts in newborn animals, 
is due to the appearance of serum factors capable of blocking otherwise reactive lym- 
phocytes from destroying cells carrying the tolerated antigens (4, 5). There are some 
recent reports supporting this concept. For example, mice made neonatally tolerant 
against allografts, as well as tetraparental  (allophenic) mice, possess both  a  cellular 
immunity against the  tolerated tissues  (detected by in  vitro tests  for lymphocyte- 
mediated cytotoxicity) and a  blocking serum  activity, i.e. an ability of  serum from 
the tolerant animals to specifically abrogate destruction by immune lymphocytes of 
cells carrying the tolerated antigens (6-9), and enhancement of tumor allografts has 
been shown after transfer of serum from mice considered to be tolerant in the classical 
sense  (4).  Furthermore,  the  coexistence  of  cell-mediated immunity  and  blocking 
serum activity has been detected in dogs, mice, and human patients, repopulated with 
foreign bone marrow after X-irradiation (10  12). 
It has been pointed out (13,  14) that the concept that animals tolerant to allografts 
have blocking serum factors and cellular immunity to the tolerated tissues is incom- 
patible with several reported observations : there have been repeated failures to trans- 
fer tolerance with serum, the tolerant state can be broken by inoculation of nontoler- 
ant syngeneic cells (15~17),  lymphocytes from tolerant rats are specifically incapable 
(as compared with  controls)  of synthesizing DNA upon  contact with  the  tolerated 
alloantigens  (18,  19),  and  mice parabiosed with  tolerant  syngeneic animals do  not 
become tolerant, as  demonstrated by skin grafting immediately upon  their  separa- 
tion from the tolerant partners  (20). 
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In  order  to  clarify whether  or not  the  blocking  serum  activity,  detected  in 
vitro,  plays  any role in  the establishment  and/or  maintenance  of tolerance  in 
vivo, there  is a  need for studies  in  which  the  same  animals  are  serially tested 
for tolerance in vivo and in which the tolerance is correlated with cell-mediated 
immunity  and  blocking  serum  activity  in  vitro  after  various  manipulations 
known  to induce or to break  tolerance. Analogous "vertical" studies on tumor- 
bearing  rats  have  been  helpful  in  elucidating  the  role  of  blocking  serum  ac- 
tivity for tumor growth  in  vivo  (21).  As  one  step  in  this  direction,  we  have 
tried  to  induce  allograft  tolerance  by neonatally  inoculating  B/N  and  W/Fu 
rats  with  allogeneic  (W/Fu  or B/N)  bone  marrow  cells,  following previously 
published procedures  (16,  17); rats were referred to as tolerant if they accepted 
skin grafts from the strain  to which tolerance induction had been attempted for 
at least 50 (generally more than  100)  days.  The subject of this paper is the ex- 
amination of cell-mediated immunity and blocking serum activity, as detected 
in vitro by using a  microcytotoxicity test  (22),  and  to study  the correlation of 
the blocking serum activity with the ability of such  rats  to accept a  skin graft 
from the respective "tolerated" strain. 
Materials and Methods 
Animals.--Rats of the inbred  (brother-sister  mated)  W/Fu and B/N strains were used. 
These rats permanently accept skin grafts within each strain.  They were maintained  on a 
standard pellet diet and water given ad libitum. 
Induction of Tolerance in Newborn Rats.--W/Fu and B/N rats were neonatally inoculated 
with allogeneic  (B/N and W/Fu) bone marrow cells, as described below. 
The long bones (humerus, femur, and tibia) and  the iliac bones were removed aseptically 
from adult  female rats  that  were used  as donors.  Bone marrow cells were flushed  out  by 
forcing Eagle's F12 medium  (containing i  U heparin/ml)  through the bone marrow canals. 
The cell suspensions  were filtered through  surgical gauze, centrifuged for 15 rain  at 220  g, 
and washed twice. Cell viability was checked by trypan blue exclusion. 
Newborn rats  (6-12 h old)  were inoculated through the anterior facial vein with the allo- 
geneic bone marrow cells, using established procedures  (16, 17). W/Fu newborn rats received 
40-42  >(  10  6 nucleated cells from B/N rats,  suspended in 0.1  ml of F12 medium; whereas, 
B/N newborns received 18-20 )< 106 W/Fu nucleated cells, also suspended in 0.1 ml vol. 
Rats were referred  to as tolerant if they accepted skin grafts from the strain  to which 
tolerance induction had been attempted for at least 50 days; most rats accepting their grafts 
for that time also kept them when examined more than 100 days after grafting, thus fulfilling 
stringent criteria for tolerance (17). Rats carrying a healthy first skin graft accepted a second 
graft put on 15 or more days after the first one; on those occasions  when the first graft was 
later rejected, the second graft was rejected at the same time. The acceptance of second skin 
grafts served as additional evidence that tolerance had been achieved. 
Untreated control rats rejected the allogeneic B/N or W/Fu grafts, the median survival 
time for 10 B/N rats getting W/Fu grafts being  ll.9  ±  0.3  days,  and  for 24 W/Fu rats 
getting B/N grafts 10.3 ±  0.4 days. 
Skin Grafling.--The skin grafting technique used was slightb' modified from one described 
by Billingham and Silvers (16). Rats were anesthetized with sodium pentobarbital, giving 35 
mg/kg body weight. A 2.5  )< 2.5 cm piece of allogenelc  skin was grafted in a bed prepared by 
excising the skin down to the deep fascia on the lateral chest wall of the recipient. The rats 
were then given a piaster bandage, which was removed on day 7 or 8, when the graft condi- 592  CELL-MEDIATED  IMMUNITY  AND  BLOCKING  SERUM  ACTIVITY 
tion was first recorded.  New checks of the graft were made daily between the 9th and  14th 
days, after which the grafts were checked every 2nd day. The bandage was temporarily re- 
moved for checking up to the llth-14th days, when it was discarded. 
Target Cells.--Fibrohlasts  were  cultivated  from  lungs  explanted  from  newborn  B/N, 
W/Fu, and (B/N X  W/Fu)F1 rats. The cells were maintained in culture,  using Waymouth's 
medium with 20~/o fetal calf serum. 
Sera.--All  test animals were  bled  at  different time points from  the  tail vein.  Sera were 
separated  and  stored at  --20°C  until tested.  Control sera were obtained from normal B/N 
and W/Fu rats and were stored in the same way. 
Separation of Blood Lymphocytes.--1.5 ml vol of heparinized blood  were drawn from the 
femoral veins of experimental and control rats. Lymphocytes were separated by centrifugation 
on cushions of silica gel with different densities, using a  technique described by Pertoft et al. 
(23). 
In Vitro Assays of Lymphocyte-Mediated Cytotoxicity.--Blood Iymphocytes from B/N  and 
W/Fu  rats, inoculated with W/Fu  or B/N  bone marrow cells as newborns, were tested for 
ability to destroy W/Fu  and B/N  fibroblasts, both sets of fibroblasts being simultaneously 
tested  with  both  types  of  rats.  In  some  experiments  (B/N  X  W/Fu)F1  fibroblasts  were 
used as well. The previously described microcytotoxicity technique (22) was employed. Lym- 
phocyte doses between 0.75  X  105 and 3  X  105  (occasionally also 0.4  X  10  ~)  were tested. 
There  was a  minimum of  eight  replicates  per  lymphocyte dose.  Percentage  of  target  cell 
numbers after  exposure to  experimental group lymphocytes was calculated  by  comparison 
with groups receiving the same dose of control lymphocytes. The outline of this type of ex- 
periment is shown in Table I. 
In  Vitro Assays of Serum Blocking Activity.--The  microcytoxicity test was also used  to 
search for serum blocking activity, which is defined as the ability of a  serum to specifically 
abrogate  target  cell  destruction  by immune lymphocytes.  The  assays were  performed  by 
TABLE  I 
Presentation of One Experiment Performed to Test the Cytotoxic Effect of Peripheral Blood 
Lymphoeytes, Using a Microcytotoxicity Assay 
no. of remaining attached W/Fu fibroblasts/well 
(mean :t= SE) with indicated no. of lymphocytes 
LymI~hocyte donor 
Normal B/N rat 
B/N,  no.  20  inocu- 
lated  with  W/Fu 
cells* 
B/N,  no.  22  inocu- 
lated  with  W/Fu 
cells* 
Sensitized B/N  rat~  31.5  4-  0.9 
I  3 X 105  1.5 X  10  a  0.75 X  t0  s  0.4 X 105 
67.2  4-  1.963.7  .55  .  q-  1.659.0  4-  1.6 
45.6  4-  1.352.4  =t:  2.450.1  4-  2.1  NT§ 
.449.8  44.7  4-  1.251.5  4-  1  4-  0.9  NT 
35.0  4-  1.5,'34.4  4-  1.137.2  4-  1.2 
i 
no. of remaining 
attached B/N 
fibroblasts/well 
(mean -4- SE) 
with indicated no. 
of ]yml)hocytes 
3 X 105 
36.1  4-  1.3 
33.7  =t=  1.3 
38.4  4-  0.9 
36.4  4-  1.2 
* B/N  rats nos. 20 and 22 were neonatally inoculated with W/Fu  bone marrow cells and 
tested at age 42 days. They accepted skin grafts from W/Fu  for  >98 days and 34 days, re- 
spectively. 
Normal  adult B/N  rat  sensitized  wi~h a  W/Fu  skin  ~raft.  Blood  lvmnhocvtes tested 
soon after graft rejection. 
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incubating  target cells with serum for 45 rain after which the serum was decanted and lympho- 
eytes added  (22). Sera were diluted 1:6 in Eagle's F12 medium before testing. Each serum 
was then tested for its ability to block destruction of B/N and W/Fu fibroblasts by lymph 
node ceils from specifically sensitized W/Fu and B/N rats.  About one-third of the sera was 
also tested  in combination with  (B/N  X  W/Fu)F1 target  ceils. Normal B/N and W/Fu 
sera were always included as controls. One experiment of this type is shown in detail in Table 
II. 
Blocking serum activity was calculated as the ability of a test serum, in comparison with a 
normal syngeneic serum, to abrogate cell-mediated destruction of the respective target  cells, 
100% blocking activity meaning that a serum could completely abrogate  detectable cyto- 
toxicity. 
The statistical significance of blocking serum activity and of destruction of target cells by 
experimental group as  compared with control  lymphocytes was calculated  by performing 
Student's t tests. 
Immunized Rats.--As  a  source of immune lyrnphocytes when testing  sera for  blocking 
activity, lymph node cells were harvested from three types of immunized rats: (a) W/Fu and 
B/N rats were twice immunized with B/N and W/Fu cells given as 107 pooled spleen, thy- 
mus, bone marrow, and lymph node cells per rat;  (b) W/Fu and B/N adult rats received 
B/N and W/Fu skin allografts and were used as immune donors after  rejection of these 
grafts; (c) rats from group b were inoculated with allogeneic  cells as outlined under a, starting 
8-10 days after skin graft rejection. 
RESULTS 
Cell-Mediated  Immunity.--A  study  was  conducted  to  determine  whether 
blood lymphocytes from rats that had been neonatally inoculated with foreign 
bone marrow cells could destroy cultivated lung fibroblasts of  the respective 
types, as compared with lymphocytes from normal B/N and W/Fu rats. The 
experimental outline is shown in Table I. Data on W/Fu rats given B/N cells 
are presented in Tables III and IV and data on B/N  rats given W/Fu  cells 
are shown in Table V. 
The majority of rats  were  tested in vitro before they were  skin grafted in 
order to check for tolerance to the respective allogeneic tissue in vivo. At that 
time,  lymphocytes from  23  of  24  rats  were  found  to  be  cytotoxic  to  target 
cells taken from the  strain whose cells were  used for  the inoculation, and no 
difference in the  degree  of reactivity was  seen between those  rats  that  later 
proved to be tolerant and the nontolerant animals. The lymphocyte cytotoxicity 
was less than that of controls sensitized with skin grafts as adults (but never 
inoculated neonatally). The latter still had  cytotoxic lymphocytes at  a  dose 
of 0.75 X  105 and 0.4 X  105 cells per well, while the former's lymphocyte effect 
was only detected when 1.5  X  105 (19 of 21 rats)  and 3  X  105 (23  of 24 rats) 
lymphocytes were added per well. The lymphocyte suspensions were not cyto- 
toxic when concomitantly tested on syngeneic target cells. 
Four rats (nos. 1, 4, 20, 23)  were studied when they had carried one tolerated 
skin graft for 48-55 days and a  second one for 4-30 days. All these rats had 
detectable cell-mediated immunity. This was higher in the rats carrying skin 
grafts than it had been when the same animals were tested earlier in their life, 
before skin grafting. It was of the same order of magnitude as in concomitantly TABLE  II 
Presentation  of One Complete Experiment  Performed to  Test Blocking Serum Activity,  i.e.,  the 
Ability of Serum to Abrogate the Cytotoxic Effect of Sensitized  Lymph Node Cells 
Target cells  Lymph node 
cell donor  Serum donor* 
B/N lung fibro- 
blasts 
W/Fu  lung  fi- 
broblasts 
Normal W/Fu 
Normal B/N 
W/Fu  sensi- 
tized to B/N I 
B/N sensitized 
to W/Fu 
Normal W/Fu 
Normal B/N 
W/Fu  sensi- 
tized to B/N 
B/N sensitized 
to W/Fu 
L 
! 
I 
Normal W/Fu 
Normal B/N 
B/N Itl W/Fu 
W/Fu It  ~ B/N 
Normal W/Fu 
Normal B/N 
B/N rt' W/Fu 
W,/Fu ~t I B/N 
Normal W/Fu 
Normal B/N 
B/N 't  I W/Fu 
W/Fu ~t  ~ B/N 
Normal W/Fu 
Normal B/N 
B/N 't' W/Fu 
W/Fu 't  t B/N 
Normal W/Fu 
Normal B/N 
B/N 't' W/Fu 
W/Fu ~t  I B/N 
Normal W/Fu 
Normal B/N 
B/N 't' W/Fu 
,  W/Fu  't'  B/N 
Normal W/Fu 
Normal B/N 
B/N 't' W/Vu 
W/Fu ~t  r B/N 
Normal W/Fu 
Normal B/N 
B/N 't' W/Fu 
W/Fu 't' B/N 
no. of remaining  Percent 
attached target  cytotoxicity with 
cells/well  3 M 10  5 lymph 
(mean  :t= SE)  node cells/well§ 
43.5  4-  1.3 
40.0  4-.1.1 
40.7  4-  1.9 
43.5  4-  0.8 
36.7 
42.8 
43.7 
38.0 
23.5 
22.0 
20.7 
32.2 
4-1.1 
4-  1.6 
4-1.7 
4-  1.2 
4-  1.0 
4-  1.0 
4-0,9 
4-  0.9 
36.6  4-  0.9 
41.6  4-  1.7 
43.8  4-  1.5 
36.7  4-  1.1 
30.1  4- 
NT{ 
46.4  4- 
29.4  4- 
33.1  ± 
46.5  -4- 
43.7  4- 
41.1  4- 
1.0 
1.7 
1.l 
1.1 
1.8 
1.6 
1.3 
29.1  4-  1.0 
NT 
43.2  4-  1.5 
30.7  4-  0.9 
1 
21.4  4-  0.7 
29.5  4-  1.1 
34.7  4-  1.2 
25.2  4-  1.0 
i 
46.0H 
45.0!1 
49.1/I 
26.0[1 
0.3  (NS) 
2.9 (NS) 
--0.2 (NS) 
3.5 
3.4 (NS) 
NT 
6.9 (NS) 
--4.4  (NS) 
35.41t 
36.6!1 
20.6¶ 
38.711 
Per- 
cent 
block- 
ing 
43.5][ 
43.711 
All sera were diluted 1:6. 
* Sera tested from normal rats (for controls), from B/N rats inoculated with W/Fu  cells 
as newborns for tolerance induction (B/N ~t t W/Fu) and from W/Fu rats similarly inoculated 
with B/N cells (W/Fu ~t  ~ B/N). The tolerant serum donors studied in this experiment were 
no. 23  (B/N Pt' W/Fu) and no. 3  (W/Fu ~t r B/N) that are further described in Tables IV 
and  V.  } NT  =  not  tested.  § Probabilities that  differences between  experimental 
and control groups are due to chance are indicated:  ¶  P  <  0.01,  /I P  <  0.001,  NS  =  not 
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TABLE  III 
Cell-Mediated Immunity  in  W/Fu  Rats  That Received B/N  Bone Marrow  Cells  as  Newborns 
W/Fu  Status of B/N skin graft  test rat 
First graft  Second graft 
no.  Sex  Age of  Sur-  Age of  Sur- 
test  rival  test  rival 
rat  of  rat  of 
when  skin  when  skin 
grafted  graft  grafted  graft 
Time 
after 
birth 
when 
tested 
Cell-mediated  immunity* 
Percent cytotoxicity by indicated 
no.  of test lymphoeytes on B/N fibroblasts 
3  X  I0  ~  1.5  X  105  0.75  X  105  4  X  l0 ~ 
days  days  days  days  days 
9  M  42  47  74  15  35  28. l ][  24.7¶  NT  NT 
11  F  42  10  74  7  35  37.911  26.5]!  NT  NT 
12  F  42  I0  74  7  35  37.91r  33.8fr  NT  NT 
13  F  42  10  74  7  35  34.6II  41.7[[  NT  NT 
14  M  37  >147  69  >115  44  29.111  28.711  3.2(NS)  NT 
164  53.3¶  6. ,3 (NS)  NT  NT 
15  M  37  >147  69  >115  44  26.911  30.111  --3.2(NS)  NT 
16  M  37  12  69  7  44  31.3][  32. III  0.6(NS)  NT 
18  F  37  12  69  7  44  51.3[I  NT~  3.7 (NS)  NT 
30  F  40  122  69  90  44  32.2II  NT  3.7 (NS)  NT 
31  M  52  >128  82  >98  40  42.9]]  33. III  9.6(NS)  NT 
32  M  52  14  68  I0  40  39.611  22.,~11  /.6(NS)  NT 
33  M  52  >128  82  >~8  40  40.5II  30.3/[  -6.8(NS)  NT 
160  --13.8(NS)  NT  NT  NT 
34  M  52  >128  82  >88  40  50.911  43.4II  7.1(NS)  NT 
35  M  52  >128  82  >88  40  47.811  NT  -0.2(NS)  NT 
38  M  46  >113  86  >73  147  3.0(NS)  NT  NT  NT 
153  4.6(NS)  --20.1(NS)  NT  NT 
40  M  46  >113  86  >73  147  3.8(NS)  NT  NT  NT 
41  M  46  >113  86  >73  147  19.3§  28.6¶  NT  NT 
42  M  46  >113  86  >73  146  68.81[  15.4(NS)  NT  NT 
50  M  45  >113  60  >98  140  30.611  --3,1(NS)  NT  NT 
51  M  56  >100  113  >43  140  21.1][  30.011  NT  NT 
52  M  56  >100  109  >47  47  30. ll]  24.4U  16.7§  NT 
140  31. ,51[  30. 511  NT  NT 
53  F  55  Died  47  33.11]  23.7I]  --10.8(NS)  NT 
54  F  55  Died  47  8.7(NS)  f2.5(NS)  4.9(NS)  NT 
55  F  55  Died  47  31.9[I  26.9I]  3.9(NS)  NT 
57  M  52  Died  47  29.7¶  15.1 (NS)  7.7(NS)  NT 
60  M  53  >100  105  >47  147  18.6¶  40.0H  NT  NT 
skin graft-  7  days  52.1II  46.21/  32.711  28.711 
sensi-  after 
tized  graft 
W/Fu rat  rejec- 
tion 
* The cytotoxic  effect was tested on B/N and, in some experiments, also on  (B/N  X  W/Fu)F1  target ceils. 
It was calculated from comparisons with groups receiving the same doses of lymphocytes from normal  (nonlnocu* 
lated) W/Fu rats. Probabilities  that differences between experimental and control groups are due to chance are 
indicated: § P  <  0.05,  ¶  P  <  0.01,  II P  <  0.001,  NS =  not significant (P >  0.05). The same lymphocyte suspen~ 
sions were also tested on W/Fu fibroblasts, on which they had no significant cytotoxic effects. 
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tested rats nos.  6  and 22,  which had  rejected their skin grafts in spite of the 
fact that they had received allogeneic cells as newborns. 
13 rats were also tested after they had carried tolerated skin grafts for 84-143 
days. 9 of these rats had a  significant cell-mediated cytotoxicity with 3  X  105 
lymphocytes per well, while only 4 of the 13 rats were reactive with 1.5  X  105 
lymphocytes per  well.  This  indicates  that  the  cell-mediated  immunity  was 
lower  when  tested  late  after tolerance  induction  than  it  was when  the  tests 
were performed closer in time to the neonatal inoculation  (and skin grafting). 
Tests on rats nos. l, 14, and 33 illustrate this point. 
The number of circulating lymphocytes in the neonatally inoculated animals 
varied between 4.2  and 8.0  :t=  106/ml,  when  determined before the first  skin 
grafting. It was not different from that of control rats. 
Blocking Serum  Activily.--An  experiment performed to search for blocking 
serum activity in neonatally inoculated rats is presented in detail in Table II, 
and our whole material is summarized in Tables IV and V. 
Sera  from rats  inoculated  neonatally  with  allogeneic  cells  and  capable  of 
accepting  skin  grafts  of  the  respective  types  for  prolonged  periods  of  time 
could block the cytotoxic effect of sensitized lymphocytes. The blocking effect 
was specific: Sera from W/Fu  rats tolerant  to B/N  cells blocked destruction 
of B/N but not of W/Fu target cells (and vice versa). No significant difference 
was  seen,  under  the  conditions  of  our  experiments,  dependent  on  whether 
control  serum from W/Fu  or  B/N  rats was  used  with  a  given set  of target 
cells. A specific blocking effect was also detected in tests on (B/N X  W/Fu)F1 
hybrid fibroblasts 
A  remarkable  correlation  was  found  between  serum  blocking  activity  in 
vitro  and  skin  graft survival  in  vivo  (Tables IV  and  V).  Sera  from all  rats 
that carried allogeneic skin grafts over prolonged periods of time were blocking 
before grafting and remained so as long as the grafts were kept (the latest serum 
sample tested was taken  129  days after grafting). Three rats  (nos.  6,  25,  and 
26)  had  sera  that  were  blocking both before  and  shortly  after grafting,  but 
lost the blocking activity within 7  10 days before rejection; these rats rejected 
their grafts after 20-27  days.  Sera from rat no.  4,  which  carried its first skin 
graft for 96 days, were blocking 17 days (but not 3 days) before graft rejection. 
Sera from rats that had rejected their grafts were never blocking in the dilution 
tested (1:6). 
DISCUSSION 
At least two conclusions can be drawn from the present observations. First, 
they  show  that  rats behave  similarly to  the  previously studied  mice  (6),  in 
that most neonatally inoculated animals that accept foreign skin grafts of the 
respective strains over prolonged periods of time have lymphocytes cytotoxic 
to target cells carrying the tolerated antigens and in that they have a blocking 
serum  activity capable of canceling  this  cytotoxicity. It may not  necessarily 
have  been  so,  since  lymphocytes from tolerant  rats  have been  shown  to  be BANSAL, HELLSTROM, HELLSTROM, AND  SJOGREN  599 
specifically nonreactive in mixed leukocyte tests (18,  19).  Second, our findings 
point  towards  a  corre]ation between the in  vitro parameters measured  (lym- 
phocyte-mediated cytotoxicity and  blocking serum activity)  and  the in  vivo 
situation,  in  that  blocking  serum  activity was  seen  to  disappear  before  the 
rejection of previously accepted skin grafts in those rats in which  such rejec- 
tions occurred. The blocking factors are believed to be antigen-antibody com- 
plexes  or  antibodies,  rather  than  antigens,  since  allogeneic  serum  from  the 
tolerated strain did not block under the conditions of our tests; no studies on 
the nature of the blocking factors in tolerant rats have been conducted,  how- 
ever. Neither have we studied  the nature  of the  "killer" cells detected in the 
tolerant  animals  (B?,  T?, macrophages?)  or their mechanisms of action.  One 
cannot exclude, therefore, that animals with cytotoxic blood lymphocytes are 
deficient with respect to (some of) those T  cell clones that are capable of react- 
ing  against  the  tolerated  antigens. 
The  cytotoxic  effect  of  lymphocytes  from  tolerant  animals  decreased  in 
strength as the time interval between neonatal inoculation  (and skin grafting) 
and the test increased, and 4 of 13 rats that were carrying skin grafts for 84 or 
more  days  were  nonreactive  (in  the  highest  dose  tested)  while  lymphocytes 
from 23  of 24  rats  tested  within  2  mo after birth  had  a  cytotoxic effect.  A 
similar decrease of detectable cell-mediated immunity has been  seen in  some 
human  patients carrying allogeneic kidney grafts (24),  to which  they initially 
reacted,  while  on  the  other  hand,  it  was  not  observed in  radiation-induced 
canine  chimeras  (10)  or in  tetraparental  mice (8).  One possibility is that the 
loss (decrease)  of cell-mediated immunity represents a more complete form of 
tolerance which is qualitatively different from that  involving coexistent  cellu- 
lar immunity and blocking serum activity. This tolerance may, indeed, be due 
to  the  elimination  of "forbidden  clones."  It may also,  however,  be due  to  a 
more effective blocking of otherwise reactive cell  clones making  cytotoxicity 
undetectable under the experimental conditions used so far. Whichever alterna- 
tive is correct (or even if none of them is), one must realize that, in the present 
studies,  those  rats  that  lacked lymphocyte reactivity when  tested  late  after 
tolerance induction,  indeed had such reactivity earlier and that this reactivity 
(presumably blocked by serum factors in vivo) was fully compatible with sur- 
vival  of  ("tolerance  to")  skin  grafts.  It  remains  to  be  studied  whether  the 
blocking serum activity disappears with time in those rats that have lost their 
ceil-mediated reactivity. 
Although our data fit the hypothesis that a blocking serum activity, as meas- 
ured in  vitro,  plays a  role in  the  maintenance  of allograft tolerance in vivo, 
it is too early to arrive at conclusions as to the importance of that role as com- 
pared  with  other  mechanisms  until  more  is known  about  how  the  in  vitro 
observations  correlate  with  the  nonreactive  state  in  vivo.  For  example,  one 
needs to know whether there are changes in blocking serum activity and in the 
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tolerant lymphocytes (or specifically immune lymphocytes) in order to break 
the tolerant state. One also wants to know whether tolerance can be transferred 
if large enough quantities  of serum are given so that samples taken from ani- 
mals receiving tolerant serum will block lymphocyte cytotoxicity when tested 
in vitro; when experiments of this type were performed with syngeneic tumors 
carrying  specific  antigens,  using  sera  from  tumor-bearing  animals,  it  was 
indeed  possible  to  show  that  sera  blocking  lymphocyte  reactivity  in  vitro 
could  enhance  tumor  growth  in  vivo  (25).  Furthermore,  one  wonders  what 
information concomitantly performed mixed leukocyte assays will give on the 
same rats.  It is not unlikely that an animal may be found to be nonreactive 
with that assay but still reactive in the microcytotoxicity test, because of the 
different cellular functions  (and,  possibly, different cellular clones)  studied by 
the two tests. Answers to these questions may be obtained by studying tolerant 
rats with presently available in  vitro assays, particularly since the same ani- 
mals can be tested repeatedly. Finally, we want to emphasize, once more, that 
we have used  the  term "tolerance" in  a  strictly operational  sense:  rats  were 
referred to  as tolerant if they retained  their skin grafts for at least 50  (com- 
monly more than 100) days. The possibility remains that rats in which tolerance 
is induced  according to some protocol different from the one we followed, re- 
ceiving, e.g. much larger inocula of foreign cells neonatalty, will  behave differ- 
ently (e.g. like our rat no. 38 in Table IIl that lacked detectable lymphocyte 
cytotoxicity). Even if it would be so, however, this would not detract from the 
interest of the demonstration that rats can retain skin grafts over long periods 
of  time  (permanently?)  in  the  presence  of  sensitized  lymphocytes and  that 
blocking serum factors appear to play an important role in making this possible. 
SUM3IARY 
W/Fu  rats  were  neonatally  inoculated  with  bone  marrow  cells  from B/N 
rats and vice versa. Of the inoculated rats,  some were capable of accepting a 
foreign (B/N or W/Fu)  skin graft over the period of observation (i.e. for more 
than  100  days), while  other rats rejected their skin grafts as early as control 
animals  (within  8-12  days)  or after a  prolonged period  of acceptance  (20-96 
days). 
Using a  microcytotoxicity test, it could be shown that both those rats that 
rat)idly rejected skin grafts and those that kept their grafts during the observa- 
tion period had lymphocytes capable of destroying cultivated  allogeneic  cells 
from the  respective strains with  whose  cells  the  rats bad been  inoculated  as 
newborns. The degree of lymphocyte reactivity decreased upon time, so that 4 
of 13 rats that had carried "tolerated" skin grafts over more than 84 days had 
lymphocytes which were nonreactive in the highest dose tested, and the degree 
of reactivity in the other 9 rats was less than seen ear])- after tolerance induc- 
tion. 
Rats that were capable of accepting skin  grafts  over prolonged  periods  of BANSAL~ HELLSTROM, I-IELLSTROM~  AND  SJOGREN  601 
time had sera that could specifically block lymphocyte-mediated cytotoxicity, 
while sera from rats that had rejected their grafts did not block. Sera from rats 
that rejected their skin grafts after 20-96 days lost the blocking activity 3-10 
days before rejection. 
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